Providing cost effective AYUSH services, with a universal access is one of the strategies to improve the quality and outreach of Healthcare Services. The erstwhile Centrally Sponsored Scheme for Development of AYUSH Hospitals & Dispensaries has been merged into National AYUSH Mission (NAM) as per the approval of Union Cabinet on 15.09.2014.
A healthy growth
The demand for Ayurveda, Yoga, Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) and herbal products is surging in India and abroad.
The wellness sector includes segments such as alternative therapies, beauty, fitness and nutrition, among others.Of these, rejuvenation services such as spas, alternative therapies, Ayurveda treatments and beauty services are expected to grow at around 30%, while the fitness sector (which includes gyms and slimming centres) is expected to grow by more than 25%.
The wellness business in India is projected to grow at a CAGR of 30-35% over the next 5 years with the business of leisure growing in popularity.
The wellness industry covers several sub-segments, including leisure, fitness, general health, medical tourism and even winding down/get-away tourism.
- India's medical tourism sector, estimated to be worth USD 3 bn in 2015, is projected to grow to USD 7-8 bn by 2020.
100% FDI allowed in AYUSH sector.
for more details refer link
- Vast AYUSH infrastructure comprising of ~736,600 registered practitioners in India
- 1,50,000 Heath Sub centres in India will be transformed into Health and Wellness Centres in 2017-18
- World's second largest exporter of ayurvedic & alternative medicine
The wellness industry in India is poised to grow at a CAGR of nearly 12% to reach USD 23 bn by FY 20 from USD 13 bn in FY 15.
The wellness industry could be further segmented into following subsectors with their share of contribution:
- Beauty care: 40%
- Nutritional care: 27%
- Fitness centres: 16%
- Alternate therapy: 15%
- Rejuvenation: 2%
Alternate therapy has been growing at a significant pace in India. The domestic trade of the Ayurveda, Yoga, Unani, Siddha and Homoeopathy (AYUSH) industry is of the order of USD 1.3 bn. The Indian medicinal plants and their products also account for exports in the range of USD 153 mn.
- Total variety of medicinal plants available in India
- Population dependent on Ayurveda and medicinal plants
- Industries engaged in AYUSH drug manufacturing
- Total variety of Indigenous herbal plants available in India
FDI inflows (in USD) in hospitals and diagnostic centres during April 2000 - September 2017
FDI permitted in the AYUSH sector
FDI inflows (in USD) in medical and surgical appliances during April 2000 - September 2017
January 2017 - Abraaj Group, a Dubai-based private equity investment firm, is in advanced discussions to acquire a controlling stake in south India’s leading diagnostics services provider Medall Healthcare Pvt Ltd, at an enterprise value of around USD 225 mn.
November 2016 - Max Healthcare, a healthcare institute based in New Delhi, has plans to invest US$ 48 mn to build a cancer care hospital in Delhi, being a part of Max's larger plan to develop its hospital in Saket.
November 2016 - Thyrocare Technologies, a diagnostic laboratory chain, plans to expand its lab centres from 7 to 25 and franchisees from 1,200 to 5,000 to achieve a target revenue of USD 150 mn by 2020.
October 2016 - UAE-based Gamma Group has outlined plans of investing around USD 449.6 mn in the infrastructure, health and education sectors of Kerala, which is expected to generate around 2,000 indirect and direct jobs in the state.